Featured Research

from universities, journals, and other organizations

Poorly coordinated care doubled risk of drug and medical errors in seven countries, study finds

Date:
June 20, 2011
Source:
Wiley-Blackwell
Summary:
Poorly coordinated care increases the likelihood of medication and medical errors by up to 200% and cost-related barriers increase the likelihood by up to 160 percent, according to a new study. Being hospitalized, having multiple chronic conditions and making greater use of health care services were also associated with the risk of errors. Research covered nearly 12,000 patients from seven countries.

Patients who received poorly coordinated care or were unable to afford basic medical costs were much more likely to report medication, treatment or care errors, according to an international study published in the July issue of IJCP, the International Journal of Clinical Practice.

Researchers from the USA and Australia used data from the Commonwealth Fund International Health Policy Survey to identify the key risk factors behind the errors reported by patients from Canada, USA, the Netherlands, UK, Germany, Australia and New Zealand. Eleven per cent of the 11,910 people surveyed said that they had experienced a medication or medical error in the last two years.

Poorly coordinated care increased the likelihood of medication and medical errors by 110% to 200% across the countries, with the highest levels in the Netherlands, followed by Germany and the UK. Cost-related barriers increased the likelihood of medication and medical errors by 50% to 160%, with the highest levels in the UK, followed by New Zealand and Australia.

Being hospitalised, having multiple chronic conditions and making greater use of healthcare services were also associated with the risk of errors.

"Medication errors are a serious safety concern, a major cause of adverse drug events and one of the most preventable causes of patient injury" says lead author Dr Christine Lu from Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, USA.

"Previous research suggests that incidence rates are as high as 6.5% in adult inpatients and more than 27% in adult outpatients and that 5% to 8% per of hospital admissions are due to adverse drug events. Medication errors can happen when they are prescribed, dispensed or administered and all countries need to find ways to reduce them, together with errors in medical treatment and care."

The study was based on data from a telephone survey carried out in 2007, using randomly selected numbers, but weighted to reflect the adult populations in each country. A multivariate analysis was carried out to calculate the odds ratios for the potential factors.

Key findings of the study included:

UK: 1,434 patients, average age 53, 61% female

9% reported medication/medical errors. Of these, 23% reported poorly coordinated care (increasing the likelihood of error by 160%) and 21% reported cost-related barriers (increasing the likelihood of error by 160%).

USA: 2,500 patients, average age 52, 62% female

13% reported medication/medical errors. Of these, 27% reported poorly coordinated care (increasing the likelihood of error by 140%) and 21% reported cost-related barriers (increasing the likelihood of error by 90%).

Canada: 3,003 patients, average age 50, 54% female

10% reported medication/medical errors. Of these, 24% reported poorly coordinated care (increasing the likelihood of error by 150%) and 22% reported cost-related barriers (increasing the likelihood of error by 90%).

Australia: 1,009 patients, average age 51, 64% female

13% reported medication/medical errors. Of these, 28% reported poorly coordinated care (increasing the likelihood of error by 110%) and 24% reported cost-related barriers (increasing the likelihood of error by 100%).

New Zealand: 1,000 patients, average age 49, 61% female

11% reported medication/medical errors. Of these, 28% reported poorly coordinated care (increasing the likelihood of error by 160%) and 21% reported cost-related barriers (increasing the likelihood of error by 110%).

Germany: 1,407 patients, average age 46, 53% female

9% reported medication/medical errors. Of these, 20% reported poorly coordinated care (increasing the likelihood of error by 160%) and 17% reported cost-related barriers (increasing the likelihood of error by 90%).

Netherlands: 1,557 patients, average age 55, 59% female

12% reported medication/medical errors. Of these, 35% reported poorly coordinated care (increasing the likelihood of error by 200%) and 30% reported cost-related barriers (increasing the likelihood of error by 50%).

Other factors that increased the overall risk included:

  • Seeing two or more specialists (Australia, Canada, USA, Netherlands)
  • Being hospitalised in the last two years (Australia, Canada, USA, Netherlands)
  • Paying two or more emergency room visits (Australia, New Zealand, USA, Germany, Netherlands)
  • Having two or more chronic illnesses (Canada, UK, USA)
  • Suffering from depression (USA, UK, Germany)
  • Having diabetes or cancer (Canada)
  • Being aged 18 to 29 rather than 65 plus (Canada, USA, Netherlands).

"The two key factors that determined medical errors were poor care coordination and cost-related barriers" says Dr Lu. "One interesting finding is that a notable proportion of patients reported cost-related barriers, even in countries where there is universal healthcare coverage.

"We believe that our findings provide important information for clinicians and policy makers alike and could help to reduce medical and medication errors."


Story Source:

The above story is based on materials provided by Wiley-Blackwell. Note: Materials may be edited for content and length.


Journal Reference:

  1. C. Y. Lu, E. Roughead. Determinants of patient-reported medication errors: a comparison among seven countries. International Journal of Clinical Practice, 2011; 65 (7): 733 DOI: 10.1111/j.1742-1241.2011.02671.x

Cite This Page:

Wiley-Blackwell. "Poorly coordinated care doubled risk of drug and medical errors in seven countries, study finds." ScienceDaily. ScienceDaily, 20 June 2011. <www.sciencedaily.com/releases/2011/06/110620103850.htm>.
Wiley-Blackwell. (2011, June 20). Poorly coordinated care doubled risk of drug and medical errors in seven countries, study finds. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2011/06/110620103850.htm
Wiley-Blackwell. "Poorly coordinated care doubled risk of drug and medical errors in seven countries, study finds." ScienceDaily. www.sciencedaily.com/releases/2011/06/110620103850.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins